BMKCloud Log in
条形banner-03

News

 

Biomarker Technologies and TIANGEN Biotech signed a strategic cooperation agreement in the European market

On February 5, 2024, Biomarker Technologies (BMKGENE) and TIANGEN Biotech (Beijing)Co., Ltd. signed a strategic cooperation agreement in the European market. BMKGENE becomes the strategic partner for TIANGEN TGuide S16 automated nucleic acid extractor and reagentin 10 European countries, further expanding the service matrix in the field of life sciences and providing customers with more comprehensive and diversified one-stop sequencing solutions. At the same time, BMKGENE will create deeper cooperation with TIANGEN in the field of laboratory automatization, taking market demand as the starting point to provide our customers with customized sequencing solutions from nucleic acid extraction to bioinformatics analysis. The cooperation combines the resource advantages of both parties to promote the expansion of the biotechnology market, jointly achieve the strategic goal of win-win cooperation and empower the biotechnology industry.